Association of Hyperandrogenemic and Metabolic Phenotype with Carotid Intima-Media Thickness in Young Women with Polycystic Ovary Syndrome
The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS), a common endocrinopathy of women of reproductive age, is associated with the early appearance of multiple risk factors for cardiovascular disease, such as abdominal obesity, dyslipidemia, and diabetes mellitus. However, premature atherosclerosis of the carotid artery has not yet been demonstrated in young women with PCOS. Measurement of carotid intima-media thickness (IMT) is considered an easy and reliable index of subclinical atherosclerosis, which is predictive of subsequent myocardial infarction and stroke. To evaluate the cardiovascular risk of PCOS and the participation of the hyperandrogenemic and metabolic pattern, we measured carotid IMT by B-mode ultrasound as well as hormonal and several cardiovascular disease-associated parameters in 75 young women with PCOS and 55 healthy, age- and body mass index-matched women. The PCOS women had significantly increased carotid IMT (0.58 vs. 0.47 mm, P < 0.001) and abdominal adiposity; higher levels of androgens, insulin, homeostasis model assessment score of insulin sensitivity, and total and low-density lipoprotein-cholesterol; and significantly lower levels of SHBG and high-density lipoprotein-cholesterol. In the studied population (n = 130), PCOS status, age, body mass index, and parental history of coronary heart disease were strong positive predictors of carotid IMT, whereas dehydroepiandrosterone sulfate was a strong negative predictor. In PCOS patients lower delta4-androstenedione and high-density lipoprotein-cholesterol levels were additionally strong positive predictors of carotid IMT, whereas in control women only total cholesterol was the additional positive predictor of carotid IMT. In conclusion, young women with PCOS have an early increase of cardiovascular risk factors and greater carotid IMT, both of which may be responsible for subclinical atherosclerosis. The hyperandrogenemic phenotype of the syndrome may attenuate the consequences of the dysmetabolic phenotype on the vascular wall.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Young women and adolescents with PCOS have been shown to have early atherosclerotic CVD, including increased carotid intimal medial thickness and carotid plaque.86, 87, 88, 89”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [87]
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
Berenson, G. S., Srinivasan, S. R., Bao, W., Newman, W. P., Tracy, R. E., & Wattigney, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382302 · Cited by 4,032
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Bots, M. L., Hoes, A. W., Koudstaal, P. J., Hofman, A., & Grobbee, D. E. (1997) · Circulation · doi:10.1161/01.cir.96.5.1432 · Cited by 2,345
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/er.18.6.774 · Cited by 1,155
Wild, S., Pierpoint, T., McKeigue, P., & Jacobs, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01000.x · Cited by 970
Cited by
Epidemiology, diagnosis, and management of polycystic ovary syndrome
Sirmans, S., & Pate, K. (2013) · Clinical Epidemiology · doi:10.2147/clep.s37559 · Cited by 1,302
Franks, S. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.1.89 · Cited by 806
Mechanistic Pathways of Sex Differences in Cardiovascular Disease
Regitz-Zagrosek, V., & Kararigas, G. (2017) · Physiological Reviews · doi:10.1152/physrev.00021.2015 · Cited by 732
Lipid Levels in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
Wild, R. A., Rizzo, M., Clifton, S., & Carmina, E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.027 · Cited by 477
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
RetractedPolycystic ovarian syndrome (PCOS): Long-term metabolic consequences
Anagnostis, P., Tarlatzis, B. C., & Kauffman, R. P. (2018) · Metabolism · doi:10.1016/j.metabol.2017.09.016 · Cited by 416
Regensteiner, J. G., Golden, S., Huebschmann, A. G., Barrett-Connor, E., Chang, A. Y., Chyun, D., Fox, C. S., Kim, C., Mehta, N., Reckelhoff, J. F., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000343 · Cited by 334
Adolescent Obesity and Puberty: The “Perfect Storm”
Jasik, C. B., & Lustig, R. H. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1429.009 · Cited by 264
Li, Y., Chen, C., Ma, Y., Xiao, J., Luo, G., Li, Y., & Wu, D. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.046 · Cited by 198
Recognition and Management of Dyslipidemia in Children and Adolescents
Kwiterovich, P. O. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1270 · Cited by 197
The metabolic syndrome in polycystic ovary syndrome
Essah, P. A., & Nestler, J. E. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03345554 · Cited by 190
Nonalcoholic fatty liver disease and polycystic ovary syndrome
Vassilatou, E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8351 · Cited by 173
Meyer, M. L., Malek, A. M., Wild, R. A., Korytkowski, M. T., & Talbott, E. O. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr046 · Cited by 175
Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives
Cussons, A. J., Stuckey, B. G. A., & Watts, G. F. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.007 · Cited by 167
Orio, F., Palomba, S., Cascella, T., De Simone, B., Manguso, F., Savastano, S., Russo, T., Tolino, A., Zullo, F., Lombardi, G., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0965 · Cited by 149
Vassilatou, E., Lafoyianni, S., Vryonidou, A., Ioannidis, D., Kosma, L., Katsoulis, K., Papavassiliou, E., & Tzavara, I. (2010) · Human Reproduction · doi:10.1093/humrep/dep380 · Cited by 142
Self-citationSathyapalan, T., Kilpatrick, E. S., Coady, A.-M., & Atkin, S. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1750 · Cited by 141
Goverde, A. J., van Koert, A. J. B., Eijkemans, M. J., Knauff, E. A. H., Westerveld, H. E., Fauser, B. C. J. M., & Broekmans, F. J. (2008) · Human Reproduction · doi:10.1093/humrep/den433 · Cited by 135
Heutling, D., Schulz, H., Nickel, I., Kleinstein, J., Kaltwasser, P., Westphal, S., Mittermayer, F., Wolzt, M., Krzyzanowska, K., Randeva, H., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0842 · Cited by 117
A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome
Shele, G., Genkil, J., & Speelman, D. (2020) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk5020035 · Cited by 115
Androgen excess: a hallmark of polycystic ovary syndrome
Wang, K., Lǐ, Y., & Chen, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1273542 · Cited by 159
The Metabolic Syndrome in Polycystic Ovary Syndrome
ESSAH, P. A., WICKHAM, E. P., & NESTLER, J. E. (2007) · Clinical Obstetrics and Gynecology · doi:10.1097/grf.0b013e31802f3547 · Cited by 113
Krentz, A. J., von Mühlen, D., & Barrett-Connor, E. (2007) · Menopause · doi:10.1097/gme.0b013e31802cc7ab · Cited by 110
Calderon-Margalit, R., Siscovick, D., Merkin, S. S., Wang, E., Daviglus, M. L., Schreiner, P. J., Sternfeld, B., Williams, O. D., Lewis, C. E., Azziz, R., et al. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.304136 · Cited by 105
Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
Sathyapalan, T., & Atkin, S. L. (2010) · Mediators of Inflammation · doi:10.1155/2010/758656 · Cited by 103
Fruzzetti, F., Perini, D., Lazzarini, V., Parrini, D., & Genazzani, A. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.004 · Cited by 95
Mechanisms IN endocrinology: metabolic syndrome through the female life cycle
Vryonidou, A., Paschou, S. A., Muscogiuri, G., Orio, F., & Goulis, D. G. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0275 · Cited by 88
Self-citationMerz, C. N. B., Shaw, L. J., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2016) · Journal of Women's Health · doi:10.1089/jwh.2015.5441 · Cited by 87
Perrino, C., Ferdinandy, P., Bøtker, H. E., Brundel, B. J. J. M., Collins, P., Davidson, S. M., den Ruijter, H. M., Engel, F. B., Gerdts, E., Girão, H., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa155 · Cited by 92
Epidemiology and Comorbidities of Polycystic Ovary Syndrome in an Indigent Population
Sirmans, S. M., Parish, R. C., Blake, S., & Wang, X. (2014) · Journal of Investigative Medicine · doi:10.1097/01.jim.0000446834.90599.5d · Cited by 79
Jensterle, M., Sebestjen, M., Janez, A., Prezelj, J., Kocjan, T., Keber, I., & Pfeifer, M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0507 · Cited by 76
Calderon‐Margalit, R., Schwartz, S. M., Wellons, M., Lewis, C. E., Daviglus, M. L., Schreiner, P. J., Williams, O. D., Sternfeld, B., Carr, J. J., O’Leary, D. H., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2643 · Cited by 76
of the Drug and Therapeutics Committee of the Pediatric Endocrine Society, Geller, D. H., Pacaud, D., Gordon, C. M., & Misra, M. (2011) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2011-9 · Cited by 72
Makhijani, R. B., Bartels, C., Godiwala, P. N., Bartolucci, A. F., DiLuigi, A. J., NULSEN, J. C., Grow, D. R., Benadiva, C. A., & Engmann, L. (2020) · Human Reproduction · doi:10.1093/humrep/deaa316 · Cited by 76
Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers
Patel, S. S., Truong, U., King, M., Ferland, A., Moreau, K. L., Dorosz, J., Hokanson, J. E., Wang, H., Kinney, G. L., Maahs, D. M., et al. (2017) · Vascular Medicine · doi:10.1177/1358863x16682107 · Cited by 65
Treatment of PCOS in adolescence
Warren-Ulanch, J., & Arslanian, S. A. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.02.002 · Cited by 68
Studen, K. B., Šebeštjen, M., Pfeifer, M., & Preželj, J. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0709 · Cited by 62
Wang, Y., Zhao, X., Zhao, H., Ding, H., Tan, J., Chen, J., Zhang, R., Azziz, R., & Yang, D. (2013) · BioMed Research International · doi:10.1155/2013/182582 · Cited by 57
Vine, D., Ghosh, M., Wang, T., & Bakal, J. (2024) · CJC Open · doi:10.1016/j.cjco.2023.12.010 · Cited by 53
Ouyang, P., Wenger, N. K., Taylor, D., Rich-Edwards, J. W., Steiner, M., Shaw, L. J., Berga, S. L., Miller, V. M., & Merz, N. B. (2016) · Biology of Sex Differences · doi:10.1186/s13293-016-0073-y · Cited by 51
Arikan, S., Akay, H., Bahceci, M., Tuzcu, A., & Gokalp, D. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.057 · Cited by 49
Fruzzetti, F., Perini, D., Lazzarini, V., Parrini, D., & Genazzani, A. R. (2009) · Gynecological Endocrinology · doi:10.1080/09513590802630146 · Cited by 49
Cardiovascular Risk Factors in Healthy Women with Previous Gestational Hypertension
Paradisi, G., Biaggi, A., Savone, R., Ianniello, F., Tomei, C., Caforio, L., & Caruso, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1337 · Cited by 53
Polotsky, A. J., Allshouse, A., Crawford, S. L., Harlow, S. D., Khalil, N., Santoro, N., & Legro, R. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3357 · Cited by 44
Glueck, C. J., Morrison, J. A., Goldenberg, N., & Wang, P. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.005 · Cited by 49
Jabbour, R., Ott, J., Eppel, W., & Frigo, P. (2020) · PLOS ONE · doi:10.1371/journal.pone.0232299 · Cited by 43
LORENZ, L. B., & WILD, R. A. (2007) · Clinical Obstetrics and Gynecology · doi:10.1097/grf.0b013e31802f5197 · Cited by 43
Alexandraki, K., Protogerou, A. D., Papaioannou, T., Piperi, C., Mastorakos, G. P., Lekakis, J. P., Panidis, D., & Diamanti‐Kandarakis, E. (2006) · HORMONES · doi:10.14310/horm.2002.11176 · Cited by 45
Vine, D., Wang, Y., Jetha, M., Ball, G., & Proctor, S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2854 · Cited by 40
Drug Therapy of Hypercholesterolaemia in Children and Adolescents
Braamskamp, M. J. A. M., Wijburg, F. A., & Wiegman, A. (2012) · Drugs · doi:10.2165/11632810-000000000-00000 · Cited by 48
Cardiometabolic abnormalities in the polycystic ovary syndrome: Pharmacotherapeutic insights
Westerveld, H. E., Hoogendoorn, M., de Jong, A. W. F., Goverde, A. J., Fauser, B. C. J. M., & Dallinga‐Thie, G. M. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.04.009 · Cited by 39
Association of sex hormones with incident 10-year cardiovascular disease and mortality in women
Schaffrath, G., Kische, H., Groß, S., Wallaschofski, H., Völzke, H., Dörr, M., Nauck, M. A., Keevil, B. G., Brabant, G. E., & Haring, R. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.08.009 · Cited by 39
Pan, H., Xian, P., Yang, D., Zhang, C., Tang, H., He, X., Lin, H., Wen, X., Ma, H., & Lai, M. (2021) · Endocrine · doi:10.1007/s12020-021-02886-9 · Cited by 39
Glueck, C. J., Aregawi, D., Agloria, M., Winiarska, M., Sieve, L., & Wang, P. (2006) · Metabolism · doi:10.1016/j.metabol.2006.08.001 · Cited by 40
Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences
Kousta, E., Tolis, G., & Franks, S. (2005) · HORMONES · doi:10.14310/horm.2002.11151 · Cited by 35
Pamuk, B. Ö., Torun, A. N., Kulaksızoğlu, M., Ertuğrul, D. T., Çiftçi, Ö., Kulaksızoğlu, S., Yıldırım, E., & Demirağ, N. G. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.10.073 · Cited by 39
Gourgari, E., Lodish, M. B., Shamburek, R. D., Keil, M. F., WESLEY, R. A., Walter, M. F., Sampson, M. L., Bernstein, S. B., Khurana, D., Lyssikatos, C., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2566 · Cited by 36
Kupreeva, M., Diané, A., Lehner, R. S., Watts, R., Ghosh, M., Proctor, S. D., & Vine, D. F. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00018.2018 · Cited by 36
Treatment of dyslipidemia in children and adolescents
Holmes, K. W., & Kwiterovich, P. O. (2005) · Current Cardiology Reports · doi:10.1007/s11886-005-0063-x · Cited by 36
Krentowska, A., Łebkowska, A., Jacewicz‐Święcka, M., Hryniewicka, J., Leśniewska, M., Adamska, A., & Kowalska, I. (2021) · Endocrine · doi:10.1007/s12020-020-02596-8 · Cited by 40
Bux, F., Favale, S., Bhuva, A., Scicchitano, P., Vito, C., Lavopa, C., Pergola, G. D., & Loverro, G. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s5639 · Cited by 32
Silva, R. D. C., Pardini, D., & Kater, C. E. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000200014 · Cited by 76
Testosterone-related shortening of QTc interval in women with polycystic ovary syndrome
Vrtovec, B., Meden‐Vrtovec, H., Jensterle, M., & Radovancevic, B. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345619 · Cited by 28
Topçu, S., Çalışkan, M., Özçimen, E. E., Tok, D., Üçkuyu, A., Erdoğan, D., Güllü, H., Yíldírír, A., Zeyneloğlu, H. B., & Müderrisoğlu, H. (2005) · Human Reproduction · doi:10.1093/humrep/dei431 · Cited by 30
Obesity, Metabolic Syndrome and Disorders of Energy Balance
Han, J. C., & Weiss, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00024-5 · Cited by 30
Topçu, S., Tok, D., Çalışkan, M., Özçimen, E. E., Güllü, H., Üçkuyu, A., Erdoğan, D., Zeyneloğlu, H. B., & Müderrisoğlu, H. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02551.x · Cited by 27
Paschou, S. Α., Palioura, E., Ioannidis, D., Anagnostis, P. G., Panagiotakou, A., Loi, V., Karageorgos, G., Goulis, D. G., & Vryonidou, A. (2017) · Endocrine Connections · doi:10.1530/ec-17-0239 · Cited by 29
Self-citationThe Polycystic Ovary Syndrome: Current Concepts On Pathogenesis And Clinical Care
Azziz, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7 · Cited by 29
Zhuang, C., Wang, Q., Wang, W., Sun, R., Zhang, F., & Yu, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.822079 · Cited by 31
Kwiterovich, P. O. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.06.003 · Cited by 29
Gul, O. B., Somunkiran, A., Yücel, O., Demirci, F., & Özdemir, İ. (2007) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-007-0401-x · Cited by 27
Polycystic Ovary Syndrome and Chronic Inflammation: Pharmacotherapeutic Implications
Sirmans, S. M., Weidman-Evans, E., Everton, V., & Thompson, D. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q514 · Cited by 24
Erdoğan, M., Karadeniz, M., Berdelı, A., Tamsel, S., & Yılmaz, C. (2009) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2009.00867.x · Cited by 24
Dagre, A. G., Lekakis, J., Mihas, C. C., Protogerou, A. D., Thalassinou, L., Tryfonopoulos, D. J., Douridas, G. N., Papamichael, C. M., & Alevizaki, M. K. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02153 · Cited by 24
Costa, L. O. B. F., dos Santos, M. P., de Oliveira, M., & Viana, A. D. O. R. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.04.005 · Cited by 25
Sun, D., Wu, Y., Ding, M., & Zhu, F. (2022) · Angiology · doi:10.1177/00033197211072598 · Cited by 20
Zhang, W., Wu, Y., Yuan, Y., Wang, L., Yu, B., Li, X., Yao, Z., & Liang, B. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.109239 · Cited by 22
Barcellos, C. R. G., Lage, S. G., Rocha, M. P., Hayashida, S. A. Y., Baracat, E. C., Romano, A., Brito, V. N., & Marcondes, J. A. M. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2012.743009 · Cited by 20
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Alexandraki, K., Eleitho Practice, A., Kandaraki, E., Poulia, K., Piperi, C., Papadimitriou, E., & Papaioannou, T. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.17.1.37 · Cited by 22
Lindholm, Å., Bixo, M., Eliasson, M., Hudecova, M., Arnadottir, R., Holte, J., & Poromaa, I. S. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.487592 · Cited by 20
Martins, W. P., Soares, G. M., Vieira, C. S., dos Reis, R. M., de Sá, M. F. S., & Ferriani, R. A. (2009) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032009000300002 · Cited by 33
Evidence for statin therapy in polycystic ovary syndrome
Sathyapalan, T., & Atkin, S. L. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810367984 · Cited by 21
Vine, D. F., Beilin, L. J., Burrows, S., Huang, R.-C., Hickey, M., Hart, R., Proctor, S. D., & Mori, T. A. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa061 · Cited by 17
Lustig, R. H., & Weiss, R. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50024-7 · Cited by 22
Kim, J., Choi, Y. M., Kang, J. H., Hwang, K. R., Chae, S. J., Kim, S. M., Ku, S., Kim, S. H., Kim, J. G., & Moon, S. Y. (2013) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2013.56.4.249 · Cited by 19
Ruberti, O. M., & Rodrigues, B. L. (2019) · Current Cardiology Reviews · doi:10.2174/1573403x15666190729153026 · Cited by 18
Genome-Wide Association Studies and Risk Scores for Coronary Artery Disease: Sex Biases
Byars, S., & Inouye, M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77932-4_38 · Cited by 17
Mechanisms of Sex Disparities in Cardiovascular Function and Remodeling
Chaudhari, S. K., Cushen, S. C., Osikoya, O., Jaini, P. A., Posey, R., Mathis, K. W., & Goulopoulou, S. (2018) · Comprehensive physiology · doi:10.1002/cphy.c180003 · Cited by 18
Hsiu, H., Hsu, W.-C., Wu, Y., Hsu, C., & Chen, C. (2013) · Microcirculation · doi:10.1111/micc.12095 · Cited by 15
Saha, S., Sarkar, C., Biswas, S. C., & Karim, R. (2008) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-008-0059-6 · Cited by 18
Ye, D., Li, M., Zhang, Y., Wang, X., Liu, H., Wu, W., Ma, W.-Y., Quan, K., Ng, E. H. Y., Wu, X., et al. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/5985703 · Cited by 15
Kao, Y., Chiu, W., Hsu, M.-I., & Chen, Y. (2013) · PubMed Central · Cited by 19
El-Kannishy, G. M., Kamal, S., Mousa, A. A., Saleh, O., Badrawy, A. E., El-Farahaty, R. M., & Shokeir, T. A. (2009) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2009.08.001 · Cited by 15
RetractedKaya, M. G., Günebakmaz, Ö., Zencır, C., Yilmazsoy, A., Karadag, M., Topsakal, R., Ergin, A., & Keleştimur, F. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.04.002 · Cited by 14
Severity and outcome of acute stroke in women: relation to adrenal sex steroid levels
Παππά, Θ., Vemmos, K. N., Saltiki, K., Mantzou, A., Stamatelopoulos, K. S., & Alevizaki, M. K. (2011) · Metabolism · doi:10.1016/j.metabol.2011.06.003 · Cited by 12
Zhang, X., Xiao, J., Liu, T., He, Q., Cui, J., Tang, S., Li, X., & Liu, M. R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.890029 · Cited by 14
Overview Of Polycystic Ovary Syndrome (PCOS)
kiran, G. U., vali, D. Y., Shankar, D. Y., Lokesh, G., Chaitanya, P. K., & Sujitha, S. (2023) · World Journal of Advanced Engineering Technology and Sciences · doi:10.30574/wjaets.2023.8.2.0052 · Cited by 12
Pandurevic, S., Bergamaschi, L., Pizzi, C., Patton, L., Rucci, P., Corzani, F., Cecchetti, C., Pelusi, C., Altieri, P., Vicennati, V., et al. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0725 · Cited by 12
The polycystic ovary syndrome (pcos) status and cardiovascular risk in young women
Ilie, I. R. P., Pepene, C. E., Marian, I., Mocan, T., Hazi, G. M., Dragotoiu, G., Ilie, R., MOCAN, L. C., & Duncea, I. (2010) · Open Medicine · doi:10.2478/s11536-010-0054-1 · Cited by 11
Treatment of dyslipidaemia in childhood
Kusters, D. M., Vissers, M. N., Wiegman, A., Kastelein, J. J. P., & Hutten, B. A. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003592169 · Cited by 12
Metadata
- Authors
- Vryonidou, A., Papatheodorou, A., Tavridou, A., Terzi, T., Loi, V., Vatalas, I.-A., Batakis, N., Phenekos, C., & Dionyssiou-Asteriou, A.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Democritus University of Thrace (GR)
- Hellenic Red Cross (GR)
- Corresponding author
- Vryonidou, Andromachi
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-05
- Volume
- 90
- Issue
- 5
- Pages
- 2740-2746
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1974985058
- Cited by
- 171
- References
- 74
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 6 · 2021: 8 · 2020: 7 · 2019: 5 · 2018: 4 · 2017: 7 · 2016: 5 · 2015: 10 · 2014: 9 · 2013: 12 · 2012: 7
- FWCI
- 17.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- polycystic ovary syndrome, carotid intima-media thickness, subclinical atherosclerosis, hyperandrogenism, cardiovascular risk, young women, abdominal fat, insulin resistance, androgens, dehydroepiandrosterone sulfate, Δ4-androstenedione, HDL cholesterol, LDL cholesterol, sex hormone-binding globulin, dyslipidemia
- MeSH terms
- Adolescent, Adult, Carotid Arteries, Female, Humans, Phenotype, Polycystic Ovary Syndrome, Prospective Studies, Body Mass Index, Multivariate Analysis, Tunica Intima, Hyperandrogenism, Dehydroepiandrosterone Sulfate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.